Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT01729104 · TERMINATED
Trial details
- NCT number
- NCT01729104
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-25
- Primary completion
- 2018-10-03
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.